HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Phenylephrine Efficacy Will Be Questioned In Citizen Petition

This article was originally published in The Tan Sheet

Executive Summary

A pharmacy professor intends to file a citizen petition asking FDA to re-examine the effectiveness of the nasal decongestant phenylephrine after the agency refused a similar request by Congress

You may also be interested in...



Patient Symptoms Are Better Measure Of Decongestant’s Efficacy – FDA

The patient self-assessed nasal congestion symptom score, not nasal air resistance, is the preferred tool to evaluate the effectiveness of an oral nasal decongestant such as phenylephrine, according to a report by a division of FDA's Office of New Drugs

Wyeth Touts PE Efficacy Claims In Comments To FDA

A letter to the editor in the July Journal of Allergy & Clinical Immunology questioning phenylephrine efficacy inappropriately downplayed positive data in favor of negative studies, Wyeth Consumer Healthcare states in comments submitted to FDA Nov. 16

Phenylephrine “Not Significantly Different From” Placebo – Schering Study

Schering-Plough released a study on phenylephrine's efficacy as compared to pseudoephedrine and placebo Oct. 31 that "raises even more questions" about the drug, according to Rep. Henry Waxman (D-Calif.)

Related Content

Topics

UsernamePublicRestriction

Register

RS125290

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel